Eric M. McLaughlin
Impact in
- Genetics top 10%
- Virus-based gene therapy research
- Chronic Lymphocytic Leukemia Research
-
- CAR-T cell therapy research
- PARP inhibition in cancer therapy
Papers in
- Oncology 14
- PARP inhibition in cancer therapy 3
- Colorectal Cancer Screening and Detection 2
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Xiaoli Zhang (3 shared papers)Electra D. Paskett (7 shared papers)Ennio Antonio Chiocca (1 shared paper)Maria Carmela Speranza (1 shared paper)Quazim A. Alayo (1 shared paper)Marco Mineo (1 shared paper)Soledad Fernandez (1 shared paper)Vivek Bhaskaran (1 shared paper)
- Journals
- Gynecologic Oncology (6 papers)Blood (4 papers)Blood Advances (2 papers)Cancers (2 papers)Journal of Surgical Research (2 papers)
- Partner nations
- United StatesSaudi ArabiaChina
In The Last Decade
Eric M. McLaughlin
64 papers receiving 558 citations
Peers
Comparison fields: 5 of 76
- Genetics 89
- Oncology 210
- Immunology 98
- Pathology and Forensic Medicine 66
- Obstetrics and Gynecology 24
Countries citing papers authored by Eric M. McLaughlin
This map shows the geographic impact of Eric M. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. McLaughlin more than expected).
Fields of papers citing papers by Eric M. McLaughlin
This network shows the impact of papers produced by Eric M. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. McLaughlin. The network helps show where Eric M. McLaughlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric M. McLaughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 115 | |
| 2 | 2021 | 55 | |
| 3 | 2019 | 55 | |
| 4 | 2021 | 33 | |
| 5 | 2017 | 29 | |
| 6 | 2023 | 15 | |
| 7 | 2022 | 15 | |
| 8 | 2022 | 14 | |
| 9 | 2019 | 12 | |
| 10 | 2019 | 11 | |
| 11 | 2023 | 11 | |
| 12 | 2018 | 10 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 8 | |
| 15 | 2019 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 7 | |
| 18 | 2022 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 2023 | 6 |
About Eric M. McLaughlin
Eric M. McLaughlin is a scholar working on Oncology, Pathology and Forensic Medicine, Immunology, Pulmonary and Respiratory Medicine and Genetics, having authored 69 papers that have together received 561 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), T-cell and Retrovirus Studies (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (3 papers), Cutaneous lymphoproliferative disorders research (3 papers), PARP inhibition in cancer therapy (3 papers), Preterm Birth and Chorioamnionitis (2 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Genetics (89 citations), Oncology (210 citations), Immunology (98 citations), Pathology and Forensic Medicine (66 citations) and Obstetrics and Gynecology (24 citations). Eric M. McLaughlin has collaborated with scholars based in United States, Saudi Arabia and China. Frequent co-authors include Xiaoli Zhang, Electra D. Paskett, Ennio Antonio Chiocca, Maria Carmela Speranza, Quazim A. Alayo, Marco Mineo, Soledad Fernandez, Vivek Bhaskaran, Hirotaka Ito and Sean Edward Lawler. Their work appears in journals such as Gynecologic Oncology, Blood, Blood Advances, Cancers and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.